Sodium Acetate Injection · 3,873 days since initial FDA posting
Brand: SODIUM ACETATE
FDA lists Sodium Acetate Injection as Active Shortage (Hikma Pharmaceuticals USA, Inc.).
Availability on file: Available
Sodium Acetate Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Sodium Acetate Injection
- Manufacturer
- Hikma Pharmaceuticals USA, Inc.
- Dosage Form
- Injection
- Presentation
- Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01)
- Package NDC
- 0641-6261-01
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Feb 3, 2016
- Last Updated
- Mar 12, 2026
- Therapeutic Category
- Endocrinology/Metabolism, Gastroenterology, Pediatric, Total Parenteral Nutrition
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Additional lots will be available. Product will be made available as it is released.
Nearby, Other Sodium Shortage Records
Sodium Acetate Injection
Fresenius Kabi USA, LLC
Injection
Sodium Acetate Injection
Milla Pharmaceuticals
Injection
Sodium Acetate Injection
Milla Pharmaceuticals
Injection
Sodium Acetate Injection
Milla Pharmaceuticals
Injection
Sodium Acetate Injection
Hospira, Inc., a Pfizer Company
Injection
Sodium Acetate Injection
Hospira, Inc., a Pfizer Company
Injection
FDA reason on file: Additional lots will be available. General shortage guidance lives on the tracker hub.